Global Preimplantation Genetic Diagnosis (PGD) Market Forecast 2019-2023Posted by sarahbennu on September 23rd, 2019 Global preimplantation genetic diagnosis market size is forecast to grow by USD 131.99 million during 2019-2023 at a CAGR over 10% with fertility clinics and maternity centers having the largest market share. Preimplantation genetic diagnosis market analysis indicates growth will be driven by increasing demand for early diagnosis of genetic disorders. Growing demand for non-invasive biopsy procedures in PGD will also fuel preimplantation genetic diagnosis industry growth. The market is driven by the increasing demand for early diagnosis of genetic disorders. In addition, the rising adoption of IVF treatments is further anticipated to boost the preimplantation genetic diagnosis (PGD) during the forecast period. Looking for more information on this market? Request a free sample report The need to prevent physical disabilities and health conditions in newborns has increased the demand for early diagnosis during genetic IVF techniques and other artificial insemination procedures. Preimplantation diagnostic tests facilitate the determination of genetic disorders by diagnosing genetic variations at the embryonic stage. Moreover, the availability of support from governments and non-profit organizations to promote the wellbeing of women and children while enabling the early diagnosis of diseases has increased awareness about the early diagnosis of genetic disorders. Thus, such initiatives by governments and non-profit organizations have increased awareness about the early diagnosis of genetic diseases and disorders, which has driven the growth of the global PGD market. Furthermore, healthcare service providers are extensively using advanced reproductive technologies, such as PGD and prenatal diagnosis, which have become an integral part of detecting the presence of genetic diseases and disorders during IVF treatments. Thus, the rising adoption of IVF treatments has increased the demand for PGD. Also, the availability of favorable reimbursements for IVF treatments has helped in addressing concerns about the high cost of these procedures. Therefore, the demand for IVF-based fertility treatments is rising, which is driving the growth of the global PGD market. The report includes detailed profiles of the leading companies & prominent vendors of the market:
Market Segmentation by Category and Product Types: The Preimplantation Genetic Diagnosis (PGD) Market can be broadly categorized into the following end-user segments:
Key Regions for the Preimplantation Genetic Diagnosis (PGD) Market: Featuring a breakdown of region wise market shares until 2019.
Some of the key topics covered in the report include: Market Landscape
Market Sizing
Vendor Landscape
Browse Full Report - http://bit.ly/2Vatg9n Like it? Share it! More by this author |